Radiopharm Theranostics Limited (ASX:RAD)
Australia · Delayed Price · Currency is AUD 0.0230
-0.0010 (-4.17%)
Aug 7, 2025, 2:21 PM AEST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of 56.76 million as of August 6, 2025. Its market cap has increased by 49.09% in one year.
Market Cap
56.76M
Enterprise Value
19.12M
Revenue
330.63K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from 101.33M to 56.76M, a decrease of -43.99%. That is a compound annual growth rate of -14.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 56.76M | 7.81% |
| Dec 31, 2024 | 52.65M | 91.43% |
| Dec 29, 2023 | 27.50M | -20.28% |
| Dec 30, 2022 | 34.50M | -65.53% |
| Dec 31, 2021 | 100.07M | -1.25% |
| Nov 25, 2021 | 101.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 130.54B |
| Pro Medicus | 33.39B |
| Cochlear | 20.52B |
| Sonic Healthcare | 13.66B |
| Ramsay Health Care | 8.66B |
| Telix Pharmaceuticals | 6.27B |
| Ansell | 4.43B |
| Mesoblast | 3.08B |